insights_auto
Why is CSBR down 2.72%?
Dive Deeperchevron_right
CSBR:NASDAQ
Champions Oncology Inc
$4.65
arrow_downward
-2.72%(-0.13) 1D
Nov 12, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
$4.64
High
$4.70
Low
$4.60
Mkt. cap
64.72M
Avg. vol.
8.11K
Volume
0.00
52-wk high
$8.31
52-wk low
$4.59
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
Open
$4.64
High
$4.70
Low
$4.60
Mkt. cap
64.72M
Avg. vol.
8.11K
Volume
0.00
52-wk high
$8.31
52-wk low
$4.59
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
News stories
From web sources and news partners
Benzinga
·
29 minutes ago
Stock Market Today: Dow Jones, S&P 500 Futures Rise, Nvidia CEO Exit Remains in Focus — CSCO, AMAT, NU in
marketscreener.com
·
5 hours ago
S&P 500 index fell after the Stockholm market closed Thursday
BeInCrypto
·
13 hours ago
S&P 500 Recovered $1 Trillion in 90 Minutes Despite Wider Market Crash
TradingView
·
3 hours ago
SPX: S&P 500 Futures Edge Higher After Nvidia Crisis, 10-Year Yield Hits 5.14%
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, United States
SectorHealth Care
Industry-
Websitechampionsoncology.com